• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时 TLC 测定药物制剂及人血浆中奈玛特韦和利托那韦的含量。

Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma.

机构信息

Pharmacy Practice Department, College of Pharmacy, Shaqra University, Shaqra, 11961, Saudi Arabia.

Clinical Pharmacy Department, National Cancer Institute, Cairo University, Fom El Khalig Square, Kasr Al-Aini Street, Cairo, 11796, Egypt.

出版信息

Sci Rep. 2023 Apr 15;13(1):6165. doi: 10.1038/s41598-023-32904-x.

DOI:10.1038/s41598-023-32904-x
PMID:37061601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10105527/
Abstract

Quantitative analysis of pharmaceutical compounds up to Nano gram levels is highly recommended to introduce feasible and sensitive tool for determination of the compounds in the pharmaceutical and biological samples. Nirmatrelvir plus ritonavir was recently approved in the US, the UK and Europe as a new co-packaged dosage form for the treatment of COVID-19. The objective of this work was to develop a more sensitive TLC method based on using β-cyclodextrin as a chiral selector additive in the mobile phase for simultaneous determination of nirmatrelvir and ritonavir in pure form, pharmaceutical formulation and spiked human plasma. The analysis procedures were developed using TLC aluminum silica gel plates and methanol-water- 2% urea solution of β-cyclodextrin (40:10:.5, by volume) as a mobile phase with UV detection at 215 nm. The developed method was successfully applied over a linearity range of 10-50 ng/band for both nirmatrelvir and ritonavir. The method was validated for limits of detection and quantitation, accuracy, precision, specificity, system suitability, and robustness. Furthermore, the eco-friendliness of the proposed method was assessed using the analytical eco-scale and the green analytical procedure index. The described method exhibited compliance with green analytical chemistry principles based on common green metric values.

摘要

推荐对药物化合物进行纳克级别的定量分析,以引入可行且灵敏的工具来测定药物和生物样品中的化合物。尼马曲韦加利托那韦最近在美国、英国和欧洲被批准为一种新的复方制剂,用于治疗 COVID-19。本工作的目的是开发一种更灵敏的 TLC 方法,即在流动相中使用β-环糊精作为手性选择添加剂,同时测定纯品、制剂和加标人血浆中的尼马曲韦和利托那韦。采用 TLC 铝硅胶板和甲醇-水-2%尿素溶液的β-环糊精(40:10:.5,体积比)作为流动相,在 215nm 处进行紫外检测,开发了分析程序。所开发的方法成功地应用于尼马曲韦和利托那韦的线性范围为 10-50ng/带。该方法已针对检测限和定量限、准确度、精密度、特异性、系统适用性和稳健性进行了验证。此外,还使用分析生态标度和绿色分析程序指数评估了所提议方法的生态友好性。所描述的方法符合基于常见绿色度量值的绿色分析化学原则。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/9afb373ef3b9/41598_2023_32904_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/c900afb763ea/41598_2023_32904_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/84ec62e8fcda/41598_2023_32904_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/01427aec0599/41598_2023_32904_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/9afb373ef3b9/41598_2023_32904_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/c900afb763ea/41598_2023_32904_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/84ec62e8fcda/41598_2023_32904_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/01427aec0599/41598_2023_32904_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b27/10105718/9afb373ef3b9/41598_2023_32904_Fig4_HTML.jpg

相似文献

1
Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma.同时 TLC 测定药物制剂及人血浆中奈玛特韦和利托那韦的含量。
Sci Rep. 2023 Apr 15;13(1):6165. doi: 10.1038/s41598-023-32904-x.
2
Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations.采用支持计算的方法对新批准的 FDA 复方制剂药物中奈玛特韦和利托那韦进行调整后的 HPLC 绿色测定。
Sci Rep. 2023 Jan 4;13(1):137. doi: 10.1038/s41598-022-26944-y.
3
Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma.在奈玛特韦存在下对利托那韦进行更高灵敏度的选择性荧光光谱测定:应用于美国食品药品监督管理局新批准的新冠病毒联合包装药物剂型及加标人血浆
BMC Chem. 2023 Sep 21;17(1):120. doi: 10.1186/s13065-023-01030-0.
4
Highly sensitive high-performance thin-layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical formulations.一种用于同时测定纯品和药物制剂中莫努匹韦、法匹拉韦和利托那韦的高灵敏度高效薄层色谱法。
J Sep Sci. 2022 Jul;45(14):2582-2590. doi: 10.1002/jssc.202200178. Epub 2022 Jun 12.
5
Simultaneous determination of nirmatrelvir and ritonavir in human plasma using LC-MS/MS and its pharmacokinetic application in healthy Chinese volunteers.采用 LC-MS/MS 法同时测定人血浆中奈玛特韦和利托那韦的浓度及其在健康中国志愿者中的药代动力学应用。
Biomed Chromatogr. 2022 Nov;36(11):e5456. doi: 10.1002/bmc.5456. Epub 2022 Aug 5.
6
Comparative HPTLC study for simultaneous determination of ivabradine and metoprolol using UV and fluorescence detectors.采用紫外和荧光检测器同时测定伊伐布雷定和美托洛尔的高效薄层色谱对比研究。
BMC Chem. 2023 Sep 14;17(1):113. doi: 10.1186/s13065-023-01025-x.
7
Simultaneous quantification of nirmatrelvir/ritonavir in human serum by LC-HRMS.LC-HRMS 同时定量测定人血清中的奈玛特韦/利托那韦。
J Pharm Biomed Anal. 2024 Jan 5;237:115796. doi: 10.1016/j.jpba.2023.115796. Epub 2023 Oct 13.
8
An eco-friendly and cost-effective HPTLC method for quantification of COVID-19 antiviral drug and co-administered medications in spiked human plasma.一种环保且经济高效的 HPTLC 方法,用于定量检测人血浆中 COVID-19 抗病毒药物和联合用药。
Sci Rep. 2024 May 1;14(1):10025. doi: 10.1038/s41598-024-56923-4.
9
Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19.采用 LC-MS/MS 同时定量检测 COVID-19 治疗患者中的奈玛特韦和利托那韦。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Dec 1;1212:123510. doi: 10.1016/j.jchromb.2022.123510. Epub 2022 Oct 17.
10
Homogeneous liquid-liquid microextraction coupled with HPLC/DAD for determination of nirmatrelvir and ritonavir as COVID-19 combination therapy in human plasma.均相液-液微萃取结合高效液相色谱/二极管阵列检测法测定人血浆中作为新冠肺炎联合治疗药物的奈玛特韦和利托那韦。
BMC Chem. 2023 Nov 24;17(1):166. doi: 10.1186/s13065-023-01080-4.

引用本文的文献

1
Dual-platform integration of HPTLC and firefly algorithm-optimized chemometrics with hammersley sequence sampling for simultaneous quantification of bisoprolol, amlodipine, and mutagenic impurity 4-hydroxybenzaldehyde.采用哈默斯利序列采样的高效薄层色谱法与萤火虫算法优化化学计量学的双平台整合,用于同时定量比索洛尔、氨氯地平和致突变杂质4-羟基苯甲醛。
BMC Chem. 2025 Aug 12;19(1):237. doi: 10.1186/s13065-025-01598-9.
2
Sustainable analysis of COVID-19 Co-packaged paxlovid: exploring advanced sampling techniques and multivariate processing tools.新冠病毒与帕罗韦德联合包装的可持续分析:探索先进采样技术和多元处理工具
BMC Chem. 2025 Jul 10;19(1):206. doi: 10.1186/s13065-025-01567-2.
3

本文引用的文献

1
Paxlovid Information From FDA and Guidance for AES Members.来自美国食品药品监督管理局(FDA)的帕罗韦德信息及对美国急诊医师协会(AES)成员的指导意见
Epilepsy Curr. 2022 Apr 4;22(3):201-204. doi: 10.1177/15357597221088415. eCollection 2022 Jun.
2
Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19.采用 LC-MS/MS 同时定量检测 COVID-19 治疗患者中的奈玛特韦和利托那韦。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Dec 1;1212:123510. doi: 10.1016/j.jchromb.2022.123510. Epub 2022 Oct 17.
3
Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form.
Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment.
用于同时测定用于治疗新冠肺炎的新复方包装剂型中奈玛特韦和利托那韦的稳定性指示反相高效液相色谱法
Sci Rep. 2025 Jan 17;15(1):2281. doi: 10.1038/s41598-025-85776-8.
4
Sustainable and technically smart spectrophotometric determination of PAXLOVID: a comprehensive ecological and analytical performance rating.帕罗韦德的可持续且技术智能的分光光度法测定:全面的生态与分析性能评级
BMC Chem. 2024 Sep 20;18(1):184. doi: 10.1186/s13065-024-01275-3.
5
Pharmacokinetic analysis of placental transfer of ritonavir as a component of paxlovid using microdialysis in pregnant rats.在妊娠大鼠中使用微透析技术对作为帕罗韦德组分的利托那韦进行胎盘转运的药代动力学分析。
Heliyon. 2024 Jan 10;10(2):e24333. doi: 10.1016/j.heliyon.2024.e24333. eCollection 2024 Jan 30.
6
Homogeneous liquid-liquid microextraction coupled with HPLC/DAD for determination of nirmatrelvir and ritonavir as COVID-19 combination therapy in human plasma.均相液-液微萃取结合高效液相色谱/二极管阵列检测法测定人血浆中作为新冠肺炎联合治疗药物的奈玛特韦和利托那韦。
BMC Chem. 2023 Nov 24;17(1):166. doi: 10.1186/s13065-023-01080-4.
7
Tailoring two white chromatographic platforms for simultaneous estimation of ritonavir-boosted nirmatrelvir in their novel pills: degradation, validation, and environmental impact studies.定制两种白色色谱平台以同时测定其新型片剂中利托那韦增强型奈玛特韦:降解、验证及环境影响研究
RSC Adv. 2023 Sep 6;13(38):26719-26731. doi: 10.1039/d3ra04186g. eCollection 2023 Sep 4.
基于计算的绿附分光光度法测定莫努匹韦;应用于最近获得 FDA 批准的药物剂型。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jan 15;285:121911. doi: 10.1016/j.saa.2022.121911. Epub 2022 Sep 22.
4
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
5
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD.为晚期慢性肾脏病患者的新冠病毒病开具奈玛特韦/利托那韦处方
Clin J Am Soc Nephrol. 2022 Aug;17(8):1247-1250. doi: 10.2215/CJN.05270522. Epub 2022 Jun 9.
6
Nirmatrelvir Plus Ritonavir: First Approval.奈玛特韦片/利托那韦片:首次获批。
Drugs. 2022 Apr;82(5):585-591. doi: 10.1007/s40265-022-01692-5.
7
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?口服奈玛特韦/利托那韦治疗新冠病毒病:黑暗中的曙光?
Antibiotics (Basel). 2022 Feb 9;11(2):220. doi: 10.3390/antibiotics11020220.
8
[Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination].[奈玛特韦片/利托那韦片组合包装(帕罗韦德),一种有效的严重急性呼吸综合征冠状病毒2 3CL蛋白酶抑制剂组合]
Rev Esp Quimioter. 2022 Jun;35(3):236-240. doi: 10.37201/req/002.2022. Epub 2022 Feb 21.
9
A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index.一种新的分析程序评估工具:绿色分析程序指数。
Talanta. 2018 May 1;181:204-209. doi: 10.1016/j.talanta.2018.01.013. Epub 2018 Jan 6.
10
Thin-layer chromatography enantioseparations on chiral stationary phases: a review.手性固定相薄层色谱对映体拆分:综述。
Anal Bioanal Chem. 2013 Jan;405(2-3):533-54. doi: 10.1007/s00216-012-6514-5. Epub 2012 Nov 17.